Sakar Healthcare Limited
NSE SAKAR.NS
Sakar Healthcare Limited Debt to Equity Ratio for the year ending March 31, 2024: 0.30
-
Sakar Healthcare Limited Debt to Equity Ratio for the year ending March 31, 2023 was 0.64, a -11.91% change year over year.
-
Sakar Healthcare Limited Debt to Equity Ratio for the year ending March 31, 2022 was 0.73, a 68.38% change year over year.
-
Sakar Healthcare Limited Debt to Equity Ratio for the year ending March 31, 2021 was 0.43, a 110.72% change year over year.
-
Sakar Healthcare Limited Debt to Equity Ratio for the year ending March 31, 2020 was 0.21, a 25.27% change year over year.
| Date | Debt to Equity Ratio | Debt to Income Ratio | Debt to Tangible Net Worth Ratio | Dividend Coverage Ratio |
|---|
Don’t Miss A Beat
| CEO | Mr. Sanjay Surendra Shah |
| IPO Date | March 16, 2017 |
| Location | India |
| Headquarters | 406, Silver Oaks Comm. Complex |
| Employees | 325 |
| Sector | Healthcare |
| Industries | |
Sakar Healthcare Limited research, develops, manufactures, and markets pharmaceutical products in India. The company provides liquid orals, cephalosporin tablets, capsules, dry powder syrups, dry powder injections, liquid injectable SVP in ampoules, vials and lyophilized injections, and oral solid dosages. Its product portfolio consists of formulations in approximately 22 therapeutic areas, such as antacid, antimalerial, anticoagulant, laxative, anthelmintic, bronchodilator, anaesthetic, antidepressant, sedative, adrenergic, anti-infective, diuretics, oxytocic, analgesic, antiemetic, antipsychotic, antifungal, PPI, anticonvulsant, anti-inflammatory, antihistamine, and multi vitamins. The company also exports its products to approximately 38 countries, including Southeast Asia, Asia, Africa-Anglo and Francophone, MENA countries, and the United States. Sakar Healthcare Limited was incorporated in 2004 and is based in Ahmedabad, India.
Past 5 years
StockViz Staff
February 3, 2025
Any question? Send us an email